Skip to content
20-F

Annual Report (Foreign)

Ping An Biomedical Co., Ltd. PASW

0001213900-26-010078

← back to feed
Filed
Jan 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Sep 30, 2025 18.48M sh
Shares Diluted FY 2025 · Sep 30, 2024 18M sh
Shares Diluted FY 2025 · Sep 30, 2023 18M sh
Shares Outstanding FY 2025 · Sep 30, 2025 20.5M sh
Operating Cash Flow FY 2025 · Sep 30, 2025 −$902.9K
Operating Cash Flow FY 2025 · Sep 30, 2025 −¥6.43M
Operating Cash Flow FY 2025 · Sep 30, 2024 ¥14.63M
Operating Cash Flow FY 2025 · Sep 30, 2023 −¥6.08M
Short Term Debt FY 2025 · Sep 30, 2025 $1.4M
Short Term Debt FY 2025 · Sep 30, 2025 ¥10M
Short Term Debt FY 2025 · Sep 30, 2024 ¥10M
Cash And Equivalents FY 2025 · Sep 30, 2025 $164.7K
Cash And Equivalents FY 2025 · Sep 30, 2025 ¥1.17M
Cash And Equivalents FY 2025 · Sep 30, 2024 ¥130.92K
Cash And Equivalents FY 2025 · Sep 30, 2023 ¥591.87K
Stockholders Equity FY 2025 · Sep 30, 2025 $6.36M
Stockholders Equity FY 2025 · Sep 30, 2025 ¥45.24M
Stockholders Equity FY 2025 · Sep 30, 2024 −¥7.19M
Stockholders Equity FY 2025 · Sep 30, 2023 −¥5.86M
Stockholders Equity FY 2025 · Sep 30, 2022 ¥4.6M
Current Liabilities FY 2025 · Sep 30, 2025 $3.24M
Current Liabilities FY 2025 · Sep 30, 2025 ¥23.08M
Current Liabilities FY 2025 · Sep 30, 2024 ¥63.58M
Total Liabilities FY 2025 · Sep 30, 2025 $3.26M
Total Liabilities FY 2025 · Sep 30, 2025 ¥23.17M
Total Liabilities FY 2025 · Sep 30, 2024 ¥64.04M
Current Assets FY 2025 · Sep 30, 2025 $8.95M
Current Assets FY 2025 · Sep 30, 2025 ¥63.7M
Current Assets FY 2025 · Sep 30, 2024 ¥53.31M
Total Assets FY 2025 · Sep 30, 2025 $9.61M
Total Assets FY 2025 · Sep 30, 2025 ¥68.41M
Total Assets FY 2025 · Sep 30, 2024 ¥56.85M
Eps Diluted FY 2025 · Sep 30, 2025 −$0.10
Eps Diluted FY 2025 · Sep 30, 2025 −¥0.69
Eps Diluted FY 2025 · Sep 30, 2024 −¥0.07
Eps Diluted FY 2025 · Sep 30, 2023 −¥0.06
Eps Basic FY 2025 · Sep 30, 2025 −$0.10
Eps Basic FY 2025 · Sep 30, 2025 −¥0.69
Eps Basic FY 2025 · Sep 30, 2024 −¥0.07
Eps Basic FY 2025 · Sep 30, 2023 −¥0.06
Sga Expense FY 2025 · Sep 30, 2025 $843.91K
Sga Expense FY 2025 · Sep 30, 2025 ¥6.01M
Sga Expense FY 2025 · Sep 30, 2024 ¥4.99M
Sga Expense FY 2025 · Sep 30, 2023 ¥3.27M
Net Income FY 2025 · Sep 30, 2025 −$1.8M
Net Income FY 2025 · Sep 30, 2025 −¥12.83M
Net Income FY 2025 · Sep 30, 2024 −¥1.28M
Net Income FY 2025 · Sep 30, 2023 −¥993.94K
Operating Income FY 2025 · Sep 30, 2025 −$2.07M
Operating Income FY 2025 · Sep 30, 2025 −¥14.7M
Operating Income FY 2025 · Sep 30, 2024 −¥2.04K
Operating Income FY 2025 · Sep 30, 2023 ¥612.48K
Gross Profit FY 2025 · Sep 30, 2025 $133.38K
Gross Profit FY 2025 · Sep 30, 2025 ¥949.51K
Gross Profit FY 2025 · Sep 30, 2024 ¥5.42M
Gross Profit FY 2025 · Sep 30, 2023 ¥4.24M
Cost Of Revenue FY 2025 · Sep 30, 2025 $4.66M
Cost Of Revenue FY 2025 · Sep 30, 2025 ¥33.2M
Cost Of Revenue FY 2025 · Sep 30, 2024 ¥82.21M
Cost Of Revenue FY 2025 · Sep 30, 2023 ¥78.32M
Revenue FY 2025 · Sep 30, 2025 $4.8M
Revenue FY 2025 · Sep 30, 2025 ¥34.15M
Revenue FY 2025 · Sep 30, 2024 ¥87.62M
Revenue FY 2025 · Sep 30, 2023 ¥82.56M
Dividends Paid FY 2025 · Sep 30, 2024 ¥322.41K
Dividends Paid FY 2025 · Sep 30, 2023 ¥9.6M